When Will Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Become Profitable?
yahoo.com
news
2022-10-18 12:05:56

With the business potentially at an important milestone, we thought we'd take a closer look at Arcturus Therapeutics Holdings Inc.'s (NASDAQ:ARCT) future prospects. Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The US$380m market-cap company's loss lessened since it announced a US$204m loss in the full financial year, compared to the latest trailing-twelve-month loss of US$165m, as it approaches breakeven.
